REPROCELL

REPROCELL provide an integrated workflow with stem cells and discovery technologies for drug development and cutting-edge Regenerative Medicine. As a global technology partner, REPROCELL has the history, expertise and flexibility to accelerate your research.

Established in 2003 by preeminent Japanese university researchers, REPROCELL quickly became the leading stem cell research company in Japan. Soon thereafter, REPROCELL products were employed by Professor Shinya Yamanaka during his pioneering research on induced pluripotent stem cell technologies at Kyoto University. REPROCELL was also the first company to offer iPSC-derived human cardiomyocytes, hepatocytes and neuronal cells for research applications. 

Across the entire organization, REPROCELL’s goal is the same; to better translate discoveries into therapies. Our global brands include: Stemgent, Biopta, Alvetex and BioServe.